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Protocol
AbstrACt
Introduction Currently, no standardised, evidence-based 
assessment tool for assessing immediate self-harm and 
suicide in acute paediatric inpatient settings exists.
Aim The aim of this study is to develop and test the 
psychometric properties of an assessment tool that 
identifies immediate risk of self-harm and suicide 
in children and young people (10–19 years) in acute 
paediatric hospital settings.
Methods and analysis Development phase: This phase 
involved a scoping review of the literature to identify 
and extract items from previously published suicide and 
self-harm risk assessment scales. Using a modified 
electronic Delphi approach, these items will then be rated 
according to their relevance for assessment of immediate 
suicide or self-harm risk by expert professionals. Inclusion 
of items will be determined by 65%–70% consensus 
between raters. Subsequently, a panel of expert members 
will convene to determine the face validity, appropriate 
phrasing, item order and response format for the finalised 
items. Psychometric testing phase: The finalised 
items will be tested for validity and reliability through a 
multicentre, psychometric evaluation. Psychometric testing 
will be undertaken to determine the following: internal 
consistency, inter-rater reliability, convergent, divergent 
validity and concurrent validity.
Ethics and dissemination Ethical approval was provided 
by the National Health Service East Midlands—Derby 
Research Ethics Committee (17/EM/0347) and full 
governance clearance received by the Health Research 
Authority and local participating sites. Findings from this 
study will be disseminated to professionals and the public 
via peer-reviewed journal publications, popular social 
media and conference presentations.
IntroduCtIon 
Mental health (MH) crisis has been defined as 
‘an acute disruption of psychological homeo-
stasis in which one’s usual coping mechanisms 
fail and there is distress and functional impair-
ment’.1 This may include: extreme anxiety or 
panic attacks; psychotic episodes (including 
delusions, hallucinations, paranoia and/or 
strengths and limitations of this study
 ► To our knowledge, this is the first UK-based study to 
develop an assessment tool to ascertain immediate 
risk of suicide and self-harm in children and young 
people presenting to acute paediatric hospital set-
tings in mental health crisis.
 ► This study seeks to address the limitations of es-
tablished assessment tools of immediate risk of 
suicide and self-harm in children and young people, 
in adherence to published psychometric evaluation 
guidelines.
 ► This protocol is tailored towards an English-speaking 
population, therefore, further national and interna-
tional testing and adaptations may be required to 
achieve wider generalisability.
 ► An opportunistic sample of self-selected experts will 
be used to inform the construction of the suicide and 
self-harm risk assessment.
 ► They may however have more motivation to take 
part than other populations and/or possess precon-
ceived investments leading them to respond in a 
particular way.
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hearing voices); hypomania or mania; other behaviours 
that feel out of control and acts of suicide or self-harm.2 
MH crisis is recognised as a psychiatric emergency as it 
is ‘an acute disturbance of thought, mood, behaviour 
or social relationship that requires immediate interven-
tion’.3 It is estimated to be the primary cause of around 
5% of emergency department (ED) attendances4 with 
the most prevalent presenting conditions being self-harm 
and/or suicidal behaviours. For these conditions alone, 
data for children and young people (CYP) aged 10–19 
years in England indicates the prevalence of suicide is 4.3 
per 100 0005 and self-harm is 435.95 per 100 000.6 
Care pathway for CYP in MH crisis
Nationally the care pathway for CYP in MH crisis varies 
considerably. The majority of acute and initial care is 
delivered by non-MH professionals in general healthcare 
settings,7 such as paediatricians and registered children’s 
nurses. Whereas specialist mental healthcare is delivered 
by professionals (including psychiatrists, nurses, social 
workers and psychologist) with specialist training, skills 
and knowledge in working with CYP with MH difficulties.8
For CYP, initial triage and care is delivered by paedi-
atricians and registered children’s nurses working in 
acute paediatric settings,9 including EDs and paediatric 
inpatient wards. The main focus of this initial part of the 
CYP care pathway is to ensure that they are appropriately 
assessed to direct a plan of care and to ensure that they 
are safe until definitive and expert MH assessment is 
undertaken.
Professionals who provide care for CYP experiencing 
MH crisis identify, it can be one of the most complex 
and stressful duties undertaken in practice.10 This could 
be attributed to the acuity of the child’s status, as crisis 
is defined as a psychiatric emergency. However, health 
professionals’ responses could also be governed by the 
perception that poor experience and outcome of this 
acute phase of the CYP care pathway may negatively 
impact on their adherence with follow-up and future 
MH. In turn, there is accumulating evidence that non-ad-
herence to follow-up is a predictor of poor outcomes, 
in terms of repeated self-harm and suicide but also in a 
variety of other psychosocial outcomes.
The assessment of CYP experiencing a MH crisis 
should involve: the identification of the main clinical 
and demographic features known to be associated with 
their MH crisis and identification of the key psychological 
characteristics associated with risk, in particular depres-
sion, hopelessness and continuing suicidal intent.11 In 
addition, any immediate physical health needs (such 
as wound care, use of antidotes, gastric irrigation and 
psychotropic medication should be addressed)12; and 
their safety should be maintained until expert assessment 
is undertaken by specialist MH professionals. However, in 
order to implement a plan of care where attempts can 
be made to mitigate immediate risks, health professionals 
(such as paediatricians and children’s nurses) need to be 
supported to make an informed assessment. Invariably 
this will have to be made in time limited circumstances 
and with CYP with potentially changing MH status. There-
fore, the assessment should focus on identifying the most 
pertinent risks (ie, immediate risk of self-harm or suicide) 
and take into account risk factors, coping abilities and 
assessment of lethality of previous suicidal and self-harm 
behaviour.13 14 Such factors can be useful to differentiate 
between high-risk and low-risk suicidal and self-harm 
behaviours.15
Assessing risk of self-harm and suicidal intent
Evidence suggests that risk assessments are no more 
accurate at predicting risk than expert specialist MH 
professional clinical judgement in non-acute psychiatric 
outpatients.16 However, acute paediatric care settings 
present specific differences in utility, focus and context 
that make the application of an assessment of suicide 
and self-harm unique.7 For example, the assessment is 
usually made by non-MH experts who may lack specialist 
knowledge and experience to inform clinical decisions. 
Furthermore, assessments are focused on immediate risks 
of self-harm or suicide during receipt of acute paediatric 
care; not projected to weeks, months or years. Addition-
ally, assessments are performed in time limited circum-
stances with CYP with potentially dynamic and fluctuating 
MH. Therefore, to enable implementation of a plan of 
care where immediate risks can be mitigated, healthcare 
professionals require appropriate support and guidance 
to inform their assessment. In current practice, risk assess-
ments of CYP suicidal or self-harm behaviour in paediatric 
inpatient departments are typically undertaken through 
a variety of non-validated tools that are often created by 
the specific department, and then generally completed 
by non-MH clinicians.17 However, some acute paediatric 
departments do use previously validated suicide risk 
assessment tools, but these tools have not been validated 
in populations presenting to acute paediatric care, very 
rarely assess immediate suicide risk and rarely include 
items on self-harm.
As such, across the UK, there is currently no stan-
dardised, specifically designed risk assessment tool being 
used within paediatric inpatient settings that assesses the 
immediate risk of self-harm or suicide for CYP experi-
encing MH crisis.
The aim of this study is to develop and provide an 
initial psychometric evaluation of an evidence-based tool 
to assess the immediate safety of CYP (aged 10–19 years) 
in MH crisis presenting to acute paediatric inpatient 
hospital settings.
Primary objectives
1. To identify relevant evidence-based self-harm and sui-
cide risk assessment tools from published literature.
2. To identify, through expert consensus, the most perti-
nent items for inclusion in a CYP-Mental Health Safe-
ty Assessment Tool (CYP-MH SAT) to assess immedi-
ate risk of self-harm and suicide in CYP experiencing 
MH crisis.
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3. To establish construct validity of a CYP-MH SAT 
through agreement from an expert panel.
4. To establish the psychometric properties of CYP-MH 
SAT in CYP presenting in MH crisis to the ED and 
inpatient wards in acute paediatric hospital settings.
MEtHods
This study incorporates three phases as outlined in 
figure 1:
Phase 1: scoping review of existing evidence
The possible domains for the development of a 
CYP-MH SAT to be used by non-expert MH profes-
sionals in an acute paediatric setting were identified 
from clinician feedback and themes identified from the 
investigation and root cause analysis of the high-level 
incidents at a local National Health Service (NHS) Trust. 
From this, the immediate risk of (1) self-harm and (2) 
suicidal behaviour were identified as the most important 
factors to be assessed by the tool.
Subsequently, we conducted a scoping review of 
published literature to identify evidence-based items 
used to assess risk of self-harm and/or suicide in CYP in 
acute inpatient settings. From this review, 22 assessment 
tools were identified, of which 12 were accessible and 
retrieved.18–29
Importantly, none of 22 assessment tools identified in 
this scoping review were specifically developed for and 
tested on a population accessing paediatric inpatient 
care in MH crisis. Thus, all items from the 12 accessible 
Figure 1 Children and Young People (CYP)-Mental Health Safety Assessment Tool study flow chart. C-SSRS, Columbia 
suicide severity rating scale.
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assessment tools were collated and grouped into themati-
cally similar subject headings using framework analysis.30 
Following removal of duplicate items and collapsing of 
similar items, a total of 93 items were identified (themes, 
subthemes and items are outlined in online supplemen-
tary table 1). These items identified from the literature 
will now be used to inform the preliminary round of the 
Delphi survey, proposed to be undertaken in phase 2a.
Phase 2a: delphi survey
The purpose of this phase is to gain consensus of the rele-
vance of items identified from the scoping review (phase 
1) using the Delphi method. The Delphi method involves 
successive questioning with a panel of experts and key 
stakeholders to develop consensus regarding a particular 
issue.31 For this study, experts and key stakeholders will be 
requested to rank the items according to their perceived 
relevance. Expertise will be defined as having experience 
of delivering care to CYP in MH crisis or having exper-
tise in CYP MH. In order to canvass the views of a range 
of experts and key stakeholders, no stipulation will be 
made as to how long they had been working in this field. 
However, information pertaining to the characteristics of 
participants was collected to explore and contextualise 
the results.
To form the panel of experts and key stakeholders, we 
will aim to recruit a purposive sample of 20–30 profes-
sionals including: Psychiatrists, Paediatricians, Nurses, 
Clinical Support Workers, Academics, Public and Patient 
Involvement representatives. Participants will be recruited 
from three NHS Trusts and two non-NHS organisations 
(Higher Education Institution and Local council). We 
would like opinions from a range of differing staff types/
grades and aim to recruit equal proportions of each staff 
type to prevent over-representation from one partic-
ular view point possibly shared by a group of individuals 
sharing the same characteristic (such as job type).32
Staff will be invited to take part by the site Local Collab-
orator via an email containing a participant information 
sheet, instructions for questionnaire completion and 
a link to a modified electronic Delphi survey (Bristol 
Online Survey: BOS software). Staff will be informed that 
completion of the survey indicates consent to take part.
The survey will consist of two sections: (1) demographics: 
email address, job title, staff grade, employing organisa-
tion, gender, date of birth and ethnicity; and (2) the list 
of items generated from phase 1 (see online supplemen-
tary table 1). Participants will be asked to rate each item 
in relation to its relevance in assessing immediate risk of 
self-harm and/or suicide for CYP presenting in MH crisis 
to acute paediatric hospital settings. Relevance to the 
assessment of immediate risk of suicide and/or self-harm 
for CYP in MH crisis in acute paediatric inpatient settings 
will be reported on a 4-point Likert scale (1-not relevant, 
2-somewhat relevant, 3-quite relevant, 4-highly relevant)33 
using a closed questioning procedure. The survey also 
allows participants to type any items they think should be 
included using open-ended questioning. The survey will 
take no longer than 15 minutes to complete and partici-
pants have 2 weeks to complete it.34 Staff will receive an 
email reminder 1 week before the return due date. Newly 
identified items from open-ended questioning will be 
included in the second iteration of the questionnaire 
to decipher consensus on the new items. Items will be 
removed if they do not achieve the prespecified consensus 
margin (≥65%–70%; median ≥3.25).35 Only items within 
the prespecific consensus margin will be redistributed 
in successive Delphi survey rounds. The survey will be 
distributed in three rounds to achieve consensus.36
Phase 2b: nominal group technique
The nominal group technique is widely used for problem 
identification, solution generation and decision-making37 
and can be used in groups of varying sizes.38 In this phase, 
respondents from phase 2a will be invited to attend a 
2-hour meeting and will be asked to provide their opin-
ions regarding face validity of the CYP-MH SAT.39 Group 
facilitators (JCM, GMW and TC) will facilitate discussions 
regarding any required changes to the tool including 
item phrasing, attribution of suitable rating scales and 
question order. When disagreements occur, opinions with 
the highest consensus in the group will be prioritised. 
The CYP-MH SAT will be considered finalised for further 
psychometric testing once the changes subject to expert 
opinion have been implemented.
Phase 3: psychometric evaluative study
The study is a multicentre, psychometric evaluation study.
Eligibility and recruitment
CYP ‘cases’ and ‘non-cases’ will be recruited from acute 
paediatric hospital settings (EDs and wards) across 
three NHS trusts in the East Midlands, UK. CYP will be 
considered eligible for recruitment based on the criteria 
outlined in box 1.
Registered clinical staff will make the initial approach to 
participants. The informed consent process will then be 
performed by trained registered clinical staff or research 
team members.
sample size and justification
Based on needing 4–10 participants per questionnaire 
item in order to conduct the psychometric testing 
procedures,40 100–200 cases and 100–200 non-cases are 
required. We envisage the CYP-MH SAT that will be eval-
uated in phase 3 will not exceed 20 items.
Measures/outcomes
Two measures will be used in this study:
1. The CYP-MH SAT: This measure is being developed 
as part of this study (phases 1 and 2) and aims to as-
sess immediate risk of self-harm and immediate risk 
of suicidality for CYP (aged 10–19 years) presenting 
to acute paediatric care. The total number of items 
and face validity will be established on completion of 
phase 2b of this study. The CYP-MH SAT will be com-
pleted with both cases and non-cases.
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2. The Columbia Suicide Severity Rating Scale (C-SSRS): 
is a clinician rated, 19-item, measure of suicide risk.41 
The C-SSRS is considered the current gold-standard 
assessment for suicide risk.42 The C-SSRS has good 
predictive validity, discriminant validity, convergent 
validity, and sensitivity and specificity.43 44 The C-SSRS 
will be completed with cases only to enable assessment 
of the level of agreement (convergent validity) with 
the CYP-MH SAT.
In addition to the measures, demographic details (date 
of birth, gender, ethnicity, NHS site, site setting, hospital 
number), primary reason for presentation to hospital 
(International Classification of Diseases-10 categories), 
MH crisis hospital presentation in the past 6 months and 
treating physician contact details will also be collected. All 
data will be collected by registered clinical staff members 
located in EDs and paediatric wards across three sites. 
All registered clinical staff members who take part in 
the study will have received CYP-MH SAT training. The 
specific training required to administer the tool will be 
dependent on its content and format that will be deter-
mined during the development of this study. The study 
steering group (composed of clinical experts) will provide 
guidance on the development of training resources. It 
is anticipated that a minimum of five people per clin-
ical area per site (n=circa 30) registered clinical staff 
members will administer the tool. We have processes in 
place to ensure that data will only be collected once from 
participants during their inpatient admission. However, if 
they are admitted again during the data collection period 
and consent to participate in the study then they will be 
counted as a new participant. Data will be collected from 
October 2017 to May 2018 (as shown in study timeline, 
figure 2), with recruitment ending earlier if sample size 
achieved.
PAtIEnt And PublIC InvolvEMEnt
The inception and design of this study has been informed 
through meaningful engagement with patient, public and 
expert professionals. CYP, their parents and carers, and 
professionals from both acute paediatric care and child 
and adolescent mental health services have informed the 
topic and focus of the study through previous stakeholder 
engagement led by JCM and funded by NHS England 
(link to full report: http :/ /epr ints .not ting ham. ac.u k/35 
284/1/ M anninget al2015PCOMN HSE ngl andFinal. pdf). 
In the development of this study, we have involved CYP to 
box 1 Eligibility criteria for entry into phase 3
Inclusion criteria
 ► Aged 10–19 years.
 ► Approved National Health Service Trust site.
 ► Cases: Presenting to acute paediatric hospital setting in mental 
health crisis as defined as: having reached ‘breaking point’, likely to 
harm themselves or others and behaviours that feel out of control, 
including: extreme anxiety or panic attacks; psychotic episodes (in-
cluding delusions, hallucinations, paranoia and/or hearing voices); 
hypomania or mania and acts of suicide or self-harm; those who 
have engaged in non-suicidal self-injury or low-lethality self-harm.
 ► Non-cases: Presenting to acute paediatric setting not in mental 
health crisis but presenting with a primary physical medical illness 
or injury. This is defined as a health problem having physical origins, 
which can be short term (eg, accidental injury, influenza, migraine, 
infections) or long term (eg, diabetes, asthma, arthritis).
 ► Mental capacity to consent.
 ► Parental/legal guardian consent and child assent (under 16 years 
old).
 ► Young person consent (over 16 years).
Exclusion criteria
 ► Unable to speak or comprehend English language.
 ► Currently receiving active end-of-life care or considered too medi-
cally ill by clinicians.
 ► Non-cases: Current mental health crisis.
Figure 2 Study timeline.
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inform the focus, design and development of study infor-
mation such as the participant information sheets.
We will continually refer to guidance on involving 
the public in research can be on the INVOLVE website 
(see: http://www. invo. org. uk/). We have referred to 
the British Council ‘Learn English’ for advice regarding 
writing for lay audiences and specific topic areas (see: 
https:// learnenglish. britishcouncil. org/ en/ writing) and 
the involve resource page (see: http://www. invo. org. uk/ 
makeitclear/ support- and- resources/). These resources 
have and will be fully used in the construction of study 
documents, procedures and dissemination activities.
In addition, a group of clinical and research experts 
have been assembled to steer the direction of this study. 
This includes staff members who provide care for CYP 
experiencing MH problems and crisis events on a daily 
basis in a range of settings that include NHS, Local 
Government and charity organisations.
Analyses
Data will be analysed using IBM SPSS (version 22) using 
statistical techniques appropriate for cross-sectional 
research. For all study phases, counts (n) and propor-
tions (%) will be calculated for categorical variables and 
descriptive statistics (mean, median, SD, range, IQR) for 
continuous variables.
Phase 2a/b
Mixed-methods analyses will be employed. Consensus 
agreement will be calculated using counts (n) and 
proportions (%) for a median relevance rating of 3.25 or 
above. Item content validity ratios (I-CVR)45 and Content 
Validity Indices (I/S-CVI)46 will be displayed as a decimal 
>0 and <1 (see figure 3). The CVR is a linear transforma-
tion of a proportional level of agreement on how many 
‘experts’ within a panel rate an item as being ‘highly 
relevant’.47 A CVI demonstrates the proportion of staff 
‘in agreement’ about the relevance (scoring either 3 or 
4) of individual items.46 Field notes will be presented in 
narrative form48 to describe consensually agreed decision 
processes during the nominal group meeting.
Phase 3
A standard psychometric approach49 50 will be taken to 
test the psychometric properties (ie, the reliability and 
validity) of the CYP-MH SAT. The factor structure will be 
analysed through exploratory factor analysis to explore 
the most parsimonious factor structure of the scale. Equiv-
alence reliability will be assessed through Cronbach alpha 
(α). Concurrent validity will be determined through 
Pearson’s correlation coefficients (or Spearman’s rank 
for non-parametric data) between the CYP-MH SAT 
and the C-SSRS. Inter-rater reliability will be established 
through Kappa coefficients (K) between CYP-MH SAT 
and inter-rater version scores from Case data (ie, two 
healthcare professionals will complete the assessment 
for each CYP to allow for a comparison between assessor 
scores). Convergent, divergent and discriminant validity 
will be determined by InterItem Correlations within 
and between assessment items and subscales. In order 
to assess convergent validity, we will correlate total scale 
scores to explore the relationship between the CYP-MH 
SAT and the C-SSRS. Discriminant/divergent validity 
will be ascertained through the correlation of case and 
non-case total scores where we would expect the scale to 
be able to differentiate between those presenting at the 
ED and children’s inpatient wards in MH crisis and those 
presenting at the ED and children’s inpatient wards not 
in MH crisis. In the case of non-normally distributed data, 
equivalent non-parametric analyses will be undertaken.
EtHICs And dIssEMInAtIon
Ethical review
The study is sponsored by the Nottingham University 
Hospitals NHS Trust, Research and Innovation depart-
ment and funded by Nottinghamshire Clinical Commis-
sioning Group. Neither the sponsor nor the funders will 
be involved in the analysis of study data or report writing.
The study did not commence prior to any approval 
mechanisms from the Sponsor Health Research 
Authority/Research Ethics Committee and Research and 
Development authorities. All study procedures will be 
conducted in line with Good Clinical Practice and NHS 
research ethical guidance.
Informed consent
All participants will be fully informed about the study 
prior to any participation in research activities in the form 
of a patient information sheet and have the opportunity 
to ask questions throughout the study.
For phases 2a and 2b of the study, staff consent will be 
implied through electronic completion of the modified 
e-Delphi questionnaire (phase 2a) and through staff 
attendance at the modified nominal group technique 
meeting (phase 2b).
For phase 3, all participation begins after a consent 
form has been signed and dated. In compliance with the 
Mental Capacity Act,51 nominee parental consent will be 
provided for children under 16 years with the opportunity 
Figure 3 Content validity equations. I-CVR, Item content 
validity ratio; I/S-CVI, content validity indices. 
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to provide written assent for themselves. Young people 
over age 16 can consent for themselves unless assessed 
by the clinician to be too medically ill or mentally inca-
pacitated. Written informed consent will indicate consent 
to notify the CYP’s hospital treating physician that they 
are participating in the study. All information will remain 
confidential and anonymised within the study team and 
regulatory authorities, unless there is indication of any 
risk of harm posed to the participant or others around 
them whereby members of the care team will be informed 
and local NHS reporting procedures followed. Anonymity 
will be ensured through the allocation of a study identi-
fication number to corresponding case report forms for 
each participant and separate storage of any patient iden-
tifiable data. All data will be stored on a secure server in 
encrypted format, with limited access permissions.
Potential participant distress and burden
While there is evidence that indicates performing a 
self-harm/suicide safety assessment is not harmful,52 we 
recognise that there is the possibility that the adminis-
tration of the CYP-MH SAT and C-SSRS may cause some 
distress to participants. Therefore, only registered clinical 
staff will be trained in study procedures and will admin-
ister the measures. In the event that participants become 
too distressed their participation will be withdrawn. All 
participants will be made aware of their right to withdraw 
at any time and voluntary participation at study concep-
tion. All participants will continue to receive usual care 
from their care team during and following their involve-
ment in the study. No care will be withheld or adapted for 
any participants taking part.
Local procedures will be adhered to in the case of 
participant disclosure throughout the course of the study. 
All staff will have received safeguarding training and know 
to share information regarding child protection as part 
of their professional practice with appropriate authorities 
(ie, social services).
Furthermore, for the CYP-MH SAT, we have integrated 
within the development phase of the tool, mechanisms 
to ensure that the items are appropriate and phrased 
sensitively. The e-Delphi procedure will apply a stringent 
prespecified consensus margin of ≥65%–70% consensus 
and a median value of 3.25, it is expected this will substan-
tially reduce the amount of question items to enable a 
rapid assessment and minimise participant exposure. 
Furthermore, the tool will be scrutinised by the expert 
panel to ensure appropriate and sensitive terminology 
and phrasing will be used for each item.
Methods of disseminating findings
This paper serves as an important step in the dissemina-
tion of the findings by outlining the project background 
and aims, details of methods used and the practical chal-
lenges that may be faced and how these will be overcome.
We intend that the findings from this study will result 
in both the development and evaluation of a clinically 
appropriate and relevant MH SAT for use with CYP in 
MH crisis. This, in turn, will provide the NHS with an 
evidence based, assessment tool that could be employed 
to enhance the safety of CYP experiencing MH crisis 
admitted to an acute paediatric inpatient setting.
The research findings will be disseminated to regional, 
national and international audiences, including service 
users, clinicians, academics, service commissioners and 
policy-makers. Study findings will be disseminated in 
peer-reviewed, high-quality academic and professional 
journals in accordance with publishing guidelines and 
provide the opportunity for participants to gain access 
to the final publication and a summary of findings in lay 
format. Findings will be presented at local, national and 
international conferences.
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